{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T08:37:47Z","timestamp":1782895067311,"version":"3.54.5"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"vor","delay-in-days":54,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["TED2021-130081B-C22"],"award-info":[{"award-number":["TED2021-130081B-C22"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018694","name":"HORIZON EUROPE Marie Sklodowska-Curie Actions","doi-asserted-by":"publisher","award":["101073222"],"award-info":[{"award-number":["101073222"]}],"id":[{"id":"10.13039\/100018694","id-type":"DOI","asserted-by":"publisher"}]},{"name":"ICREA Academia program"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Breast cancer is the leading cause of cancer-related death in women, with mortality increasing when tumor cells spread to nearby lymph nodes, particularly the axillary lymph nodes (ALNs). Although several studies predict patients with ALN metastasis at diagnosis (pdALN\n                      <jats:sup>+<\/jats:sup>\n                      ), few examine the prognostic value of immune elements within ALNs. Given the impact of immune response on breast cancer, this study develops a machine learning model to identify the clinicopathological and immune features of the primary tumor and non-metastatic ALNs (ALN\n                      <jats:sup>\u2212<\/jats:sup>\n                      ) most frequently associated with pdALN\n                      <jats:sup>+<\/jats:sup>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Two datasets of luminal breast cancer patients diagnosed between 1995 and 2008 were used: Dataset 1 involved 83 women (42 pdALN\n                      <jats:sup>\u2212<\/jats:sup>\n                      and 41 pdALN\n                      <jats:sup>+<\/jats:sup>\n                      ), and Dataset 2 comprised 344 women (204 pdALN\n                      <jats:sup>\u2212<\/jats:sup>\n                      and 140 pdALN\n                      <jats:sup>+<\/jats:sup>\n                      ). Three machine learning models were developed using the Random Forest algorithm: Model 1 included clinicopathological data from Dataset 1; Model 2 used clinicopathological and immune response data from Dataset 1; and Model 3 used clinicopathological data from Dataset 2. All models followed the same machine learning pipeline, including data pre-processing, feature selection using recursive feature elimination with cross-validation, algorithm optimization using random search cross-validation, and results interpretability using Shapley additive explanations values. After selecting the best-performing model, Model 4 was developed using its dataset and features. The optimal feature set was determined at the point where adding more features led to a decline in model performance metrics.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Model 2 outperformed Models 1 and 3, despite the larger cohort on which Model 3 was developed. This highlights the crucial role of the immune response in breast cancer progression. Model 4 achieved a median ROC AUC of 0.84, a median accuracy of 0.76, and a median recall of 0.75. Remarkably, nine of the ten predictive features were immune populations. The intratumoral follicular dendritic cell marker CD21\n                      <jats:sup>+<\/jats:sup>\n                      was the most predictive feature, even surpassing tumor diameter, a well-established prognostic factor in breast cancer. Thus, it might stand as a novel biomarker candidate.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study not only identifies promising biomarker candidates but also highlights the importance of including mechanistic features, such as mediating inflammation, in breast cancer patient stratification.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13058-026-02294-9","type":"journal-article","created":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T12:56:57Z","timestamp":1778245017000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Leveraging immune and clinicopathological profiles with machine learning to predict axillary lymph node metastasis in breast cancer patients"],"prefix":"10.1186","volume":"28","author":[{"given":"Alba","family":"Fischer-Carles","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio","family":"Fiorin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"L\u00f3pez Pablo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laia","family":"Revert\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Sauras-Col\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"No\u00e8lia","family":"Gallardo-Borr\u00e0s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryl\u00e8ne","family":"Lejeune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikel","family":"Relloso Ortiz de Uriarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T\u00e1bata","family":"S\u00e1nchez-Alc\u00e1ntara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Ballester-Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramon","family":"Bosch Pr\u00edncep","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laia","family":"Adalid-Llansa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Goyda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Mata Cano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Noailly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemma","family":"Piella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,8]]},"reference":[{"key":"2294_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"2294_CR2","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74:12\u201349.","journal-title":"CA Cancer J Clin"},{"key":"2294_CR3","doi-asserted-by":"publisher","DOI":"10.1586\/erm.11.96","author":"LB Vegu\u00e9","year":"2012","unstructured":"Vegu\u00e9 LB, Mu\u00f1oz RC, Madrona AP. Breast cancer sentinel lymph node and axillary lymphadenectomy: new tools for new challenges. Expert Rev Mol Diagn. 2012. https:\/\/doi.org\/10.1586\/erm.11.96.","journal-title":"Expert Rev Mol Diagn"},{"key":"2294_CR4","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1038\/bjc.2014.5","volume":"110","author":"E Colzani","year":"2014","unstructured":"Colzani E, Johansson ALV, Liljegren A, Foukakis T, Clements M, Adolfsson J, et al. Time-dependent risk of developing distant metastasis in breast cancer patients according to treatment, age and tumour characteristics. Br J Cancer. 2014;110:1378\u201384.","journal-title":"Br J Cancer"},{"key":"2294_CR5","doi-asserted-by":"publisher","first-page":"5574","DOI":"10.1002\/cam4.2474","volume":"8","author":"H Dillek\u00e5s","year":"2019","unstructured":"Dillek\u00e5s H, Rogers MS, Straume O. Are 90% of deaths from cancer caused by metastases? Cancer Med. 2019;8:5574\u20136.","journal-title":"Cancer Med"},{"key":"2294_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines6010020","author":"D Nagarajan","year":"2018","unstructured":"Nagarajan D, McArdle SEB. Immune landscape of breast cancers. Biomedicines. 2018. https:\/\/doi.org\/10.3390\/biomedicines6010020. (MDPI AG;).","journal-title":"Biomedicines"},{"key":"2294_CR7","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdu450","author":"R Salgado","year":"2015","unstructured":"Salgado R, Denkert C, Demaria S, Sirtaine N, Klauschen F, Pruneri G, et al. The evaluation of tumor-infiltrating lymphocytes (TILS) in breast cancer: recommendations by an International TILS Working Group 2014. Ann Oncol. 2015. https:\/\/doi.org\/10.1093\/annonc\/mdu450. (Oxford University Press;).","journal-title":"Ann Oncol"},{"key":"2294_CR8","unstructured":"Jahangir CA, Page DB, Broeckx G, Gonzalez CA, Burke C, Murphy C, et al. Image-based multiplex immune profiling of cancer tissues: translational implications. A report of the International Immuno-oncology Biomarker Working Group on Breast Cancer. J. Pathol. John Wiley and Sons Ltd; 2024. p. 271\u201388."},{"key":"2294_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2021.05.006","author":"S Jana","year":"2021","unstructured":"Jana S, Muscarella RA, Jones D. The multifaceted effects of breast cancer on tumor-draining lymph nodes. Am J Pathol. 2021. https:\/\/doi.org\/10.1016\/j.ajpath.2021.05.006. (Elsevier Inc.;).","journal-title":"Am J Pathol"},{"key":"2294_CR10","doi-asserted-by":"publisher","DOI":"10.1007\/s00418-019-01802-7","author":"A Gibert-Ramos","year":"2019","unstructured":"Gibert-Ramos A, L\u00f3pez C, Bosch R, Fontoura L, Bueno G, Garc\u00eda-Rojo M, et al. Immune response profile of primary tumour, sentinel and non-sentinel axillary lymph nodes related to metastasis in breast cancer: an immunohistochemical point of view. Histochem Cell Biol. 2019. https:\/\/doi.org\/10.1007\/s00418-019-01802-7. (Springer Verlag;).","journal-title":"Histochem Cell Biol"},{"key":"2294_CR11","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.ajpath.2019.11.002","volume":"190","author":"C L\u00f3pez","year":"2020","unstructured":"L\u00f3pez C, Bosch R, Orero G, Korzynska A, Garc\u00eda-Rojo M, Bueno G, et al. The immune response in nonmetastatic axillary lymph nodes is associated with the presence of axillary metastasis and breast cancer patient outcome. Am J Pathol. 2020;190:660\u201373.","journal-title":"Am J Pathol"},{"key":"2294_CR12","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.ajpath.2020.11.008","volume":"191","author":"C L\u00f3pez","year":"2021","unstructured":"L\u00f3pez C, Gibert-Ramos A, Bosch R, Korzynska A, Garc\u00eda-Rojo M, Bueno G, et al. Differences in the immune response of the nonmetastatic axillary lymph nodes between Triple-Negative and Luminal A breast cancer surrogate subtypes. Am J Pathol. 2021;191:545\u201354.","journal-title":"Am J Pathol"},{"key":"2294_CR13","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1007\/s12282-022-01336-2","volume":"29","author":"C L\u00f3pez","year":"2022","unstructured":"L\u00f3pez C, Bosch R, Korzynska A, Garc\u00eda-Rojo M, Bueno G, Garc\u00eda-Fontgivell JF, et al. CD68 and CD83 immune populations in non-metastatic axillary lymph nodes are of prognostic value for the survival and relapse of breast cancer patients. Breast Cancer. 2022;29:618\u201335.","journal-title":"Breast Cancer"},{"key":"2294_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.artmed.2018.06.002","author":"AN Richter","year":"2018","unstructured":"Richter AN, Khoshgoftaar TM. A review of statistical and machine learning methods for modeling cancer risk using structured clinical data. Artif Intell Med. 2018. https:\/\/doi.org\/10.1016\/j.artmed.2018.06.002. (Elsevier B.V.;).","journal-title":"Artif Intell Med"},{"key":"2294_CR15","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1007\/s11596-021-2474-3","volume":"41","author":"PR Liu","year":"2021","unstructured":"Liu PR, Lu L, Zhang JY, Huo TT, Liu SX, Ye ZW. Application of artificial intelligence in medicine: an overview. Curr Med Sci. 2021;41:1105\u201315.","journal-title":"Curr Med Sci"},{"key":"2294_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/biomedinformatics2040049","author":"K Athanasopoulou","year":"2022","unstructured":"Athanasopoulou K, Daneva GN, Adamopoulos PG, Scorilas A. Artificial intelligence: the milestone in modern biomedical research. BioMedInformatics. 2022. https:\/\/doi.org\/10.3390\/biomedinformatics2040049. (Multidisciplinary Digital Publishing Institute (MDPI);).","journal-title":"BioMedInformatics"},{"key":"2294_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.artmed.2022.102276","author":"AB Nassif","year":"2022","unstructured":"Nassif AB, Talib MA, Nasir Q, Afadar Y, Elgendy O. Breast cancer detection using artificial intelligence techniques: a systematic literature review. Artif Intell Med. 2022. https:\/\/doi.org\/10.1016\/j.artmed.2022.102276. (Elsevier B.V.;).","journal-title":"Artif Intell Med"},{"key":"2294_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.gie.2020.06.040","author":"V Kaul","year":"2020","unstructured":"Kaul V, Enslin S, Gross SA. History of artificial intelligence in medicine. Gastrointest Endosc. 2020. https:\/\/doi.org\/10.1016\/j.gie.2020.06.040. (Mosby Inc.;).","journal-title":"Gastrointest Endosc"},{"key":"2294_CR19","doi-asserted-by":"crossref","unstructured":"Lecun Y, Bengio Y, Hinton G. Deep learning. Nature. Nature Publishing Group; 2015. p. 436\u201344.","DOI":"10.1038\/nature14539"},{"key":"2294_CR20","doi-asserted-by":"crossref","unstructured":"Althnian A, AlSaeed D, Al-Baity H, Samha A, Dris A Bin, Alzakari N, et al. Impact of dataset size on classification performance: an empirical evaluation in the medical domain. Appl Sci. 2021;11:1\u201318.","DOI":"10.3390\/app11020796"},{"key":"2294_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/wics.1549","volume":"13","author":"M Tayefi","year":"2021","unstructured":"Tayefi M, Ngo P, Chomutare T, Dalianis H, Salvi E, Budrionis A, et al. Challenges and opportunities beyond structured data in analysis of electronic health records. WIREs Comput Stat. 2021;13:1\u201319.","journal-title":"WIREs Comput Stat"},{"key":"2294_CR22","doi-asserted-by":"crossref","unstructured":"Taye MM. Understanding of Machine Learning with Deep Learning: architectures, workflow, applications and future directions. Computers. MDPI; 2023.","DOI":"10.3390\/computers12050091"},{"key":"2294_CR23","doi-asserted-by":"crossref","unstructured":"Lombardi A, Amoroso N, Bellantuono L, Bove S, Comes MC, Fanizzi A, et al. Accurate evaluation of feature contributions for sentinel lymph node status classification in breast cancer. Appl Sci. 2022;12.","DOI":"10.3390\/app12147227"},{"key":"2294_CR24","doi-asserted-by":"publisher","first-page":"577","DOI":"10.12659\/MSM.890345","volume":"20","author":"JL Wu","year":"2014","unstructured":"Wu JL, Tseng HS, Yang LH, Wu HK, Kuo SJ, Chen ST, et al. Prediction of axillary lymph node metastases in breast cancer patients based on pathologic information of the primary tumor. Med Sci Monit. 2014;20:577\u201381.","journal-title":"Med Sci Monit"},{"key":"2294_CR25","doi-asserted-by":"crossref","unstructured":"Abreu PH, Santos MS, Abreu MH, Andrade B, Silva DC. Predicting breast cancer recurrence using machine learning techniques: a systematic review. ACM Comput Surv. 2016;49.","DOI":"10.1145\/2988544"},{"key":"2294_CR26","volume-title":"World Health Organization classification of tumours of the breast","author":"SR Lakhani","year":"2019","unstructured":"Lakhani SR, Ellis IO, Schnitt SJ, Tan PH, van de Vijver MJ. World Health Organization classification of tumours of the breast. 5th edn. Lyon: IARC Press; 2019.","edition":"5th edn"},{"key":"2294_CR27","doi-asserted-by":"crossref","unstructured":"L\u00f3pez C, Bosch-Pr\u00edncep R, Orero G, Balaguer\u00f3 LF, Korzynska A, Garc\u00eda-Rojo M, et al. Peritumoral immune infiltrates in primary tumours are not associated with the presence of axillary lymph node metastasis in breast cancer: a retrospective cohort study. PeerJ. 2020;8.","DOI":"10.7717\/peerj.9779"},{"key":"2294_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1475-925X-14-S2-S2","volume":"14","author":"C Callau","year":"2015","unstructured":"Callau C, Lejeune M, Korzynska A, Garc\u00eda M, Bueno G, Bosch R, et al. Evaluation of cytokeratin-19 in breast cancer tissue samples: a comparison of automatic and manual evaluations of scanned tissue microarray cylinders. Biomed Eng Online. 2015;14:1\u201311.","journal-title":"Biomed Eng Online"},{"key":"2294_CR29","doi-asserted-by":"crossref","unstructured":"Harris CR, Millman KJ, van der Walt SJ, Gommers R, Virtanen P, Cournapeau D, et al. Array programming with NumPy. Nature. Nature Research; 2020. p. 357\u201362.","DOI":"10.1038\/s41586-020-2649-2"},{"key":"2294_CR30","doi-asserted-by":"crossref","unstructured":"Mckinney W. Data Structures for Statistical Computing in Python. 2010.","DOI":"10.25080\/Majora-92bf1922-00a"},{"key":"2294_CR31","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1109\/MCSE.2007.55","volume":"9","author":"JD Hunter","year":"2007","unstructured":"Hunter JD. Matplotlib: a 2D graphics environment. Comput Sci Eng. 2007;9:90\u20135.","journal-title":"Comput Sci Eng"},{"key":"2294_CR32","first-page":"4766","volume":"30","author":"SM Lundberg","year":"2017","unstructured":"Lundberg SM, Lee SI. A unified approach to interpreting model predictions. Adv Neural Inf Process Syst. 2017;30:4766\u201375.","journal-title":"Adv Neural Inf Process Syst"},{"key":"2294_CR33","first-page":"2825","volume":"12","author":"F Pedregosa","year":"2011","unstructured":"Pedregosa F, Varoquaux G, Gramfort A, Michel V, Thirion B, Grisel O, et al. Scikit-learn: machine learning in python. J Mach Learn Res. 2011;12:2825\u201330.","journal-title":"J Mach Learn Res"},{"key":"2294_CR34","first-page":"1","volume":"18","author":"G Lema\u00eetre","year":"2017","unstructured":"Lema\u00eetre G, Nogueira F, Aridas CK. Imbalanced-learn: a Python toolbox to tackle the curse of imbalanced datasets in machine learning. J Mach Learn Res. 2017;18:1\u20135.","journal-title":"J Mach Learn Res"},{"key":"2294_CR35","doi-asserted-by":"crossref","unstructured":"Virtanen P, Gommers R, Oliphant TE, Haberland M, Reddy T, Cournapeau D, et al. SciPy 1.0: fundamental algorithms for scientific computing in Python. Nat Methods. 2020;17:261\u201372.","DOI":"10.1038\/s41592-020-0772-5"},{"key":"2294_CR36","first-page":"12","volume-title":"Soo MS","author":"KS Johnson","year":"2021","unstructured":"Johnson KS, Conant EF. Soo MS. Molecular subtypes of breast cancer: a review for breast radiologists. J. Breast Imaging. Oxford University Press; 2021. p. 12\u201324."},{"key":"2294_CR37","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/17.6.520","author":"O Troyanskaya","year":"2001","unstructured":"Troyanskaya O, Cantor M, Sherlock G, Brown P, Hastie T, Tibshirani R, et al. Missing value estimation methods for DNA microarrays. Bioinformatics. 2001. https:\/\/doi.org\/10.1093\/bioinformatics\/17.6.520.","journal-title":"Bioinformatics"},{"key":"2294_CR38","doi-asserted-by":"publisher","DOI":"10.18637\/jss.v045.i03","author":"S Van Buuren","year":"2011","unstructured":"Van Buuren S, Groothuis-Oudshoorn K. Mice: multivariate imputation by chained equations in R. J Stat Softw. 2011. https:\/\/doi.org\/10.18637\/jss.v045.i03.","journal-title":"J Stat Softw"},{"key":"2294_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.asoc.2022.109924","author":"LBV de Amorim","year":"2023","unstructured":"de Amorim LBV, Cavalcanti GDC, Cruz RMO. The choice of scaling technique matters for classification performance. Appl Soft Comput. 2023. https:\/\/doi.org\/10.1016\/j.asoc.2022.109924.","journal-title":"Appl Soft Comput"},{"key":"2294_CR40","unstructured":"Zhu W, Qiu R, Fu Y. Comparative study on the performance of categorical variable encoders in classification and regression tasks. 2024; Available from: http:\/\/arxiv.org\/abs\/2401.09682"},{"key":"2294_CR41","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s41066-017-0049-2","volume":"2","author":"H Liu","year":"2017","unstructured":"Liu H, Cocea M. Semi-random partitioning of data into training and test sets in granular computing context. Granul Comput. 2017;2:357\u201386.","journal-title":"Granul Comput"},{"key":"2294_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-018-2264-5","author":"R Couronn\u00e9","year":"2018","unstructured":"Couronn\u00e9 R, Probst P, Boulesteix AL. Random forest versus logistic regression: a large-scale benchmark experiment. BMC Bioinformatics. 2018. https:\/\/doi.org\/10.1186\/s12859-018-2264-5.","journal-title":"BMC Bioinformatics"},{"key":"2294_CR43","doi-asserted-by":"crossref","unstructured":"Mustaqim AZ, Adi S, Pristyanto Y, Astuti Y. The effect of recursive feature elimination with cross-validation (RFECV) feature selection algorithm toward classifier performance on credit card fraud detection. ICAICST 2021 - 2021 Int Conf Artif Intell Comput Sci Technol. Institute of Electrical and Electronics Engineers Inc.; 2021. p. 270\u20135.","DOI":"10.1109\/ICAICST53116.2021.9497842"},{"key":"2294_CR44","first-page":"281","volume":"13","author":"J Bergstra","year":"2012","unstructured":"Bergstra J, Benigo Y. Random search for hyper-parameter optimization. J Mach Learn Res. 2012;13:281\u2013305.","journal-title":"J Mach Learn Res"},{"key":"2294_CR45","doi-asserted-by":"crossref","first-page":"7","DOI":"10.24215\/16666038.21.e7","volume":"21","author":"R Hossain","year":"2021","unstructured":"Hossain R, Timmer DD. Machine learning model optimization with hyper parameter tuning approach. Glob J Comput Sci Technol. 2021;21:7\u201313.","journal-title":"Glob J Comput Sci Technol"},{"key":"2294_CR46","first-page":"77","volume":"7","author":"N Suba\u015f\u0131","year":"2024","unstructured":"Suba\u015f\u0131 N. Comprehensive analysis of grid and randomized search on dataset performance. Eur J Eng Appl Sci. 2024;7:77\u201383.","journal-title":"Eur J Eng Appl Sci"},{"key":"2294_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-86327-7","author":"A Moncada-Torres","year":"2021","unstructured":"Moncada-Torres A, van Maaren MC, Hendriks MP, Siesling S, Geleijnse G. Explainable machine learning can outperform Cox regression predictions and provide insights in breast cancer survival. Sci Rep. 2021. https:\/\/doi.org\/10.1038\/s41598-021-86327-7.","journal-title":"Sci Rep"},{"key":"2294_CR48","doi-asserted-by":"crossref","unstructured":"Bewick V, Cheek L, Ball J. Statistics review 10: further nonparametric methods. Crit. Care. 2004. p. 196\u20139.","DOI":"10.1186\/cc2857"},{"key":"2294_CR49","unstructured":"Conover WJ. Practical Nonparametric Statistics. 3rd Edition. Wiley; 1999."},{"key":"2294_CR50","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/his.14786","volume":"82","author":"EA Rakha","year":"2023","unstructured":"Rakha EA, Tse GM, Quinn CM. An update on the pathological classification of breast cancer. Histopathology. 2023;82:5\u201316.","journal-title":"Histopathology"},{"key":"2294_CR51","doi-asserted-by":"crossref","unstructured":"Fj\u00f8rtoft MO, Huse K, Rye IH. The tumor immune microenvironment in breast cancer progression. Acta Oncol. (Madr). Medical Journals Sweden AB; 2024. p. 359\u201367.","DOI":"10.2340\/1651-226X.2024.33008"},{"key":"2294_CR52","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/785317","author":"L De La Cruz-Merino","year":"2013","unstructured":"De La Cruz-Merino L, Barco-S\u00e1nchez A, Henao Carrasco F, Nogales Fern\u00e1ndez E, Vallejo Ben\u00edtez A, Brugal Molina J, et al. New insights into the role of the immune microenvironment in breast carcinoma. Clin Dev Immunol. 2013. https:\/\/doi.org\/10.1155\/2013\/785317.","journal-title":"Clin Dev Immunol"},{"key":"2294_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cancers14184505","volume":"14","author":"I Wall","year":"2022","unstructured":"Wall I, Boulat V, Shah A, Blenman KRM, Wu Y, Alberts E, et al. Leveraging the dynamic immune environment triad in patients with breast cancer: tumour, lymph node, and peripheral blood. Cancers (Basel). 2022;14:1\u201328.","journal-title":"Cancers (Basel)"},{"key":"2294_CR54","doi-asserted-by":"crossref","unstructured":"Gu Q, Cai Z, Zhu L, Huang B. Data mining on imbalanced data sets. Proc - 2008 Int Conf Adv Comput Theory Eng ICACTE 2008. 2008. p. 1020\u20134.","DOI":"10.1109\/ICACTE.2008.26"},{"key":"2294_CR55","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1613\/jair.953","volume":"16","author":"NV Chawla","year":"2002","unstructured":"Chawla NV, Bowyer KW, Hall LO, Kegelmeyer WP. SMOTE: synthetic minority over-sampling technique. J Artif Intell Res. 2002;16:321\u201357.","journal-title":"J Artif Intell Res"},{"key":"2294_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cancers13040757","volume":"13","author":"S Samiei","year":"2021","unstructured":"Samiei S, Granzier RWY, Ibrahim A, Primakov S, Lobbes MBI, Beets-Tan RGH, et al. Dedicated axillary MRI-based radiomics analysis for the prediction of axillary lymph node metastasis in breast cancer. Cancers (Basel). 2021;13:1\u201315.","journal-title":"Cancers (Basel)"},{"key":"2294_CR57","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11030968","author":"E Kuhn","year":"2023","unstructured":"Kuhn E, Gambini D, Despini L, Asnaghi D, Runza L, Ferrero S. Updates on lymphovascular invasion in breast cancer. Biomedicines. 2023. https:\/\/doi.org\/10.3390\/biomedicines11030968. (MDPI).","journal-title":"Biomedicines"},{"key":"2294_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2006.09.003","author":"NR Patani","year":"2007","unstructured":"Patani NR, Dwek MV, Douek M. Predictors of axillary lymph node metastasis in breast cancer: a systematic review. Eur J Surg Oncol. 2007. https:\/\/doi.org\/10.1016\/j.ejso.2006.09.003.","journal-title":"Eur J Surg Oncol"},{"key":"2294_CR59","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.12659\/MSM.890491","volume":"20","author":"HS Tseng","year":"2014","unstructured":"Tseng HS, Chen LS, Kuo SJ, Chen ST, Wang YF, Chen DR. Tumor characteristics of breast cancer in predicting axillary lymph node metastasis. Med Sci Monit. 2014;20:1155\u201361.","journal-title":"Med Sci Monit"},{"key":"2294_CR60","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15030634","author":"J Vrdoljak","year":"2023","unstructured":"Vrdoljak J, Boban Z, Bari\u0107 D, \u0160egvi\u0107 D, Kumri\u0107 M, Avirovi\u0107 M, et al. Applying explainable machine learning models for detection of breast cancer lymph node metastasis in patients eligible for neoadjuvant treatment. Cancers (Basel). 2023. https:\/\/doi.org\/10.3390\/cancers15030634.","journal-title":"Cancers (Basel)"},{"key":"2294_CR61","doi-asserted-by":"publisher","first-page":"6368","DOI":"10.1158\/1078-0432.CCR-19-0075","volume":"25","author":"L Dihge","year":"2019","unstructured":"Dihge L, Vallon-Christersson J, Hegardt C, Saal LH, H\u00e4kkinen J, Larsson C, et al. Prediction of lymph node metastasis in breast cancer by gene expression and clinicopathological models: development and validation within a population-based cohort. Clin Cancer Res. 2019;25:6368\u201381.","journal-title":"Clin Cancer Res"},{"key":"2294_CR62","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-022-03724-w","author":"ZW Guo","year":"2022","unstructured":"Guo ZW, Liu Q, Yang X, Cai GX, Han BW, Huang LM, et al. Noninvasive prediction of axillary lymph node status in breast cancer using promoter profiling of circulating cell-free DNA. J Transl Med. 2022. https:\/\/doi.org\/10.1186\/s12967-022-03724-w.","journal-title":"J Transl Med"},{"key":"2294_CR63","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14040950","author":"J Cheng","year":"2022","unstructured":"Cheng J, Ren C, Liu G, Shui R, Zhang Y, Li J, et al. Development of high-resolution dedicated PET-based radiomics machine learning model to predict axillary lymph node status in early-stage breast cancer. Cancers (Basel). 2022. https:\/\/doi.org\/10.3390\/cancers14040950.","journal-title":"Cancers (Basel)"},{"key":"2294_CR64","doi-asserted-by":"crossref","unstructured":"Zhang J, Cao G, Pang H, Li J, Yao X. Development and validation of radiomics machine learning model based on contrast-enhanced computed tomography to predict axillary lymph node metastasis in breast cancer. Bosn J Basic Med Sci. 2022;","DOI":"10.17305\/bjbms.2022.7853"},{"key":"2294_CR65","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.28086","volume":"3","author":"Y Yu","year":"2020","unstructured":"Yu Y, Tan Y, Xie C, Hu Q, Ouyang J, Chen Y, et al. Development and validation of a preoperative magnetic resonance imaging radiomics-based signature to predict axillary lymph node metastasis and disease-free survival in patients with early-stage breast cancer. JAMA Netw Open. 2020;3:e2028086.","journal-title":"JAMA Netw Open"},{"key":"2294_CR66","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s00428-011-1145-3","volume":"459","author":"AS Mansfield","year":"2011","unstructured":"Mansfield AS, Heikkila P, Von Smitten K, Vakkila J, Leidenius M. Metastasis to sentinel lymph nodes in breast cancer is associated with maturation arrest of dendritic cells and poor co-localization of dendritic cells and CD8+ T cells. Virchows Arch. 2011;459:391\u20138.","journal-title":"Virchows Arch"},{"key":"2294_CR67","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.26.856","author":"D de Jong","year":"2005","unstructured":"de Jong D. Molecular pathogenesis of follicular lymphoma: a cross talk of genetic and immunologic factors. J Clin Oncol. 2005. https:\/\/doi.org\/10.1200\/JCO.2005.26.856.","journal-title":"J Clin Oncol"},{"key":"2294_CR68","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/aqab090","author":"Y Xie","year":"2021","unstructured":"Xie Y, Jaffe ES. How i diagnose angioimmunoblastic T-cell lymphoma. Am J Clin Pathol. 2021. https:\/\/doi.org\/10.1093\/ajcp\/aqab090. (Oxford University Press).","journal-title":"Am J Clin Pathol"},{"key":"2294_CR69","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-019-0144-6","author":"C Saut\u00e8s-Fridman","year":"2019","unstructured":"Saut\u00e8s-Fridman C, Petitprez F, Calderaro J, Fridman WH. Tertiary lymphoid structures in the era of cancer immunotherapy. Nat Rev Cancer. 2019. https:\/\/doi.org\/10.1038\/s41568-019-0144-6. (Nature Publishing Group;).","journal-title":"Nat Rev Cancer"},{"key":"2294_CR70","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1111\/imr.12405","volume":"271","author":"MC Dieu-Nosjean","year":"2016","unstructured":"Dieu-Nosjean MC, Giraldo NA, Kaplon H, Germain C, Fridman WH, Saut\u00e8s-Fridman C. Tertiary lymphoid structures, drivers of the anti-tumor responses in human cancers. Immunol Rev. 2016;271:260\u201375.","journal-title":"Immunol Rev"},{"key":"2294_CR71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-021-08343-0","volume":"21","author":"SL Anwar","year":"2021","unstructured":"Anwar SL, Cahyono R, Prabowo D, Avanti WS, Choridah L, Dwianingsih EK, et al. Metabolic comorbidities and the association with risks of recurrent metastatic disease in breast cancer survivors. BMC Cancer. 2021;21:1\u201313.","journal-title":"BMC Cancer"},{"key":"2294_CR72","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2147\/CLEP.S47150","volume":"5","author":"M S\u00f8gaard","year":"2013","unstructured":"S\u00f8gaard M, Thomsen RW, Bossen KS, S\u00f8rensen HT, N\u00f8rgaard M. The impact of comorbidity on cancer survival: a review. Clin Epidemiol. 2013;5:3\u201329.","journal-title":"Clin Epidemiol"},{"key":"2294_CR73","doi-asserted-by":"crossref","unstructured":"L\u00f3pez C, Revert\u00e9 L, Bosch Pr\u00edncep R, Sauras E, Gallardo-Borr\u00e0s N, Fischer-Carles A, et al. Influence of the molecular subtype-dependent immune microenvironment of metastatic axillary lymph nodes on breast cancer patient outcomes. Pathobiology. 2025;1\u201320.","DOI":"10.1159\/000550086"}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13058-026-02294-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-026-02294-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-026-02294-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T07:08:10Z","timestamp":1782889690000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13058-026-02294-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,8]]},"references-count":73,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2294"],"URL":"https:\/\/doi.org\/10.1186\/s13058-026-02294-9","relation":{},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,8]]},"assertion":[{"value":"4 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The present study received approval from the Research Committee of the HUTVC and the Ethics Committee of HJ23 in Tarragona (reference number 22p\/2011) and the Ethics Committee of the IISPV (reference numbers 128\/2022 & 218\/2022). Written informed consent was obtained from all patients for their involvement in the study and for using their biopsy specimens and clinical data. The study adhered to the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) guidelines and to the standards of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"121"}}